X0306
4
2018-05-14
0
0001023024
ANI PHARMACEUTICALS INC
ANIP
0001579618
MARSHBANKS TRACY
C/O ANI PHARMACEUTICALS, INC.
210 MAIN STREET WEST
BAUDETTE
MN
56623
1
0
0
0
Common Stock
2018-05-14
4
S
0
5506
62.35
D
382664
I
See Footnote
Common Stock
2018-05-15
4
S
0
7024
62.05
D
375640
I
See Footnote
Common Stock
2018-05-16
4
S
0
25706
62.40
D
349934
I
See Footnote
This transaction was executed in multiple trades at prices ranging from $62.00 to $62.64. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $62.00 to $62.11. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $62.00 to $62.72. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Held by FA Private Equity Fund IV, L.P., FA Private Equity Fund IV GmbH & Co. Beteiligungs KG, The Productivity Fund IV Liquidating Trust, and The Productivity Fund IV Advisors Fund Liquidating Trust, which the Reporting Person may be deemed to be a beneficial owner pursuant to rule 16a-1(a)(1).
/s/ Tracy Marshbanks
2018-05-16